Lataa...
APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
Investigations of apolipoprotein E (APOE) gene, the major genetic risk modifier for Alzheimer’s disease (AD), have yielded significant insights into the pathogenic mechanism. Among the three common coding variants, APOE*ε4 increases, whereas APOE*ε2 decreases the risk of late-onset AD compared with...
Tallennettuna:
| Julkaisussa: | Mol Neurodegener |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7640652/ https://ncbi.nlm.nih.gov/pubmed/33148290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-020-00413-4 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|